ranking alternative public health policies. One of the key questions of cost-benefit analysis of non-pharmaceutical infectious … costs of the applied strategy. With this in mind, the aim of this paper is to point out the basic non …-pharmaceutical strategies for the control of COVID-19, the framework of their analysis and the basic costs and benefits of their application …